Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Hans, Bijlsma"'
Autor:
Judy Ammerlaan, Harmieke van Os-Medendorp, Nienke de Boer-Nijhof, Lieske Scholtus, Aike A. Kruize, Philomine van Pelt, Berent Prakken, Hans Bijlsma
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 15, Iss 1, Pp 1-13 (2017)
Abstract Background A web-based self-management intervention guided by peer-trainers was developed to support young adults’ self-management in coping with Juvenile Idiopathic Arthritis (JIA). To investigate its effectiveness, a randomized controlle
Externí odkaz:
https://doaj.org/article/91baf270d8f149ca8a9084f38727ddde
Autor:
Bijlsma, Johannes Wj, Hans, Bijlsma, Alessia, Alunno, Gerd, Burmester, Roberto, Caporali, Loreto, Carmona, Bernard, Combe, Richard, Conway, Jeffrey, Curtis, Ori, Elkayam, Laure, Gossec, Lukas, Haupt, Marloes, Heijstek, Iagnocco, Annamaria, John, Isaacs, Istvan, Juhasz, Feline, Kroon, Robert, Landewe, Pedro, Machado, Souzi, Makri, Xavier, Mariette, Iain, Mcinnes, Puja, Mehta, Ulf, Muller-Ladner, Aurelie, Najm, Victoria, Navarro-Compan, Julia, Rautenstrauch, Diana, Rodrigues, Hendrik, Schulze-Koops, Josef, Smolen, Tanja, Stamm, Thea, Vliet Vlieland, Dieter, Wiek, Kevin, Winthrop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6246432a668c23e570667fc08005f76
https://hdl.handle.net/2318/1891613
https://hdl.handle.net/2318/1891613
Autor:
Tjeerd de Jongh, Hans Bijlsma
Publikováno v:
Huisarts en wetenschap. 62:53-55
Huisartsen zien veel patienten met artrose van de knie. De aandoening is niet te genezen en de behandeling richt zich op bestrijding van de pijn. Alle richtlijnen adviseren beweging, omdat fysieke activiteit de pijn vermindert en de functie verbetert
A trustworthy clinical companion, the textbook offers best practice and management strategies for these common joint diseases. Formerly published as Osteoarthritis, the extensively revised third edition of the Oxford Textbook of Osteoarthritis and Cr
Autor:
Rinie Geenen, R.H. W.M. Derksen, A. Garssen, A. Hartkamp, J.W.J. (Hans) Bijlsma, A. A. Kruize, G. L. R. Godaert
Publikováno v:
Annals of the New York Academy of Sciences. 966:320-326
Fatigue is a well-recognized complaint with major impact on daily life in primary Sjögren's syndrome (PSS) and systemic lupus erythematosus (SLE). Previous research has not taken into account several crucial aspects of fatigue. This study examined v
Autor:
J W J Hans, Bijlsma, J W Annemarie, Hagemeijer, Marc, Bijl, Tim L Th A, Jansen, Mart A F J, van de Laar, Robert B M, Landewé, Mike T, Nurmohamed
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 155(30-31)
A multidisciplinary working group has developed a practice guideline containing various recommendations on the responsible and efficient use of biologicals. These biologicals include both soluble immune-receptor proteins and monoclonal antibodies tha
Autor:
Paco M J, Welsing, Marc, Bijl, Ad A, van Bodegraven, Willem F, Lems, Erol, Prens, J W J Hans, Bijlsma
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 155(29)
Where health care is concerned, the introduction of biologicals has greatly improved the treatment of chronic inflammatory disorders. This class of drugs is not only noticeably effective, but is also well tolerated. The cost effectiveness of these dr
Autor:
Willem F, Lems, J W J Hans, Bijlsma
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 155(29)
It is becoming clearer that early treatment of rheumatoid arthritis (RA) is useful. Recently, Dutch investigators observed a difference between RA referred early (within 12 weeks) and RA referred later (after 12 weeks). Patients who were referred ear
Autor:
Willem F, Lems, J W J Hans, Bijlsma
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 154
Polymyalgia rheumatica (PMR) is a chronic inflammatory rheumatic disorder, which predominantly occurs in patients aged 50 years and older. It can be difficult to differentiate PMR from other diseases, for general practitioners as well as for rheumato
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 153
Influenza vaccination is important in order to limit flu-related morbidity and mortality. This especially applies to immunocompromised patients, such as HIV-infected individuals and patients on immunosuppressive treatment, who have an increased risk